🧪 Systemic mastocytosis care is evolving across the disease spectrum. Explore recent clinical trial data, identify patients who may benefit from advanced treatment & ✨ evaluate whether disease control is truly adequate. 🧭 Stay ahead of SM care—register today! mdsc.pe/4yhO28u #ASH26
1
189
Managing refractory HSV in immunocompromised patients requires moving beyond IV foscarnet.
Our expert panel breaks down clinical evidence, toxicity hurdles, and oral options.
Watch the expert breakdown here ➡️ mdsc.pe/4A89e1B
#InfectiousDisease #CME #MedEd
164
How does mNGS fit into your diagnostic approach? Join experts to review available tests and best-use practices for evaluating suspected infections in immunocompromised patients.
🔗 mdsc.pe/4yt5g3c
133
🔬 How can you optimize care for patients with newly diagnosed multiple myeloma ?
Explore clinical evidence for transplant-eligible and ineligible patients, personalized treatment strategies, and the importance of collaborative care.
💡 Strengthen your clinical decision-making—join this educational activity! mdsc.pe/3U0ktts #ASH26
173
🧬 What's new in sickle cell disease (SCD) care? Explore gene therapies, emerging PK activators, and personalized treatment strategies.
🔍 Expand your clinical knowledge—join this educational activity! mdsc.pe/4zpr7Zo #ASH26
213
💊 Optimizing R/R DLBCL treatment requires evidence-based decisions! Explore bispecific antibody trial findings, treatment sequencing, and practical strategies for community-based care.
🎯 Enhance your expertise! mdsc.pe/4ex4Q3I #ASH26
202
🧬 What's new in #HER2Mutated advanced #NSCLC? 🔬 Explore emerging targeted therapies, personalized treatment strategies, and multidisciplinary approaches to identifying eligible patients. 💡 Advance your clinical expertise! mdsc.pe/48ZJUiH

ALT The image is a promotional graphic for a Medscape Global Oncology event titled "Shaping the Future of HER2-Mutated Advanced NSCLC: Precision Strategies Across the Continuum." It mentions the event date, Friday, 4 December 2026, and indicates it's a hybrid event. The graphic includes anatomical imagery of a torso in the background. The event is supported by Bayer.
184
Grow your expertise in emerging oral endocrine therapies. This new Medscape activity guides you through the latest evidence, patient selection, sequencing, and team-based strategies in early breast cancer so you can shape care with authority.
mdsc.pe/4z5AwF8
200
🧪 Advancing care for systemic mastocytosis starts with the latest evidence happening at #ASH26!
Explore clinical trial findings, assess disease control, and enhance interprofessional treatment decisions.
🚀 Stay informed—join this educational activity! mdsc.pe/4yfvJ3h
210
👉 Sharpen your approach to AL amyloidosis! 💬 Differentiate amyloid disorders, interpret treatment data, personalize therapy, and strengthen coordinated workflows to support timely, effective care. mdsc.pe/4x5jqGX
#ASH26
2
291
🩸 At #ASH26, explore the latest data on bispecific antibodies for R/R DLBCL, including when transplant or CAR T may not be suitable. Gain practical insights to inform treatment decisions. Register today: mdsc.pe/4yldhag
2
380
💊 Optimizing R/R DLBCL treatment requires evidence-based decisions! Explore bispecific antibody trial findings, treatment sequencing, and practical strategies for community-based care.
🎯 Enhance your expertise! mdsc.pe/4ex4Q3I #ASH26
Struggling to choose between DNA vs. RNA-based NGS for NTRK fusions?
Dr. Ibiayi Dagogo-Jack and Dr. Nabil F. Saba explain why RNA-based assays, and plasma testing when tissue is limited, are critical for detection.
Watch the full discussion ➡️ mdsc.pe/4jb6VFn
#CME #Oncology #NTRK
231
🧬 Choosing the right TKI in CML starts with the right data. Explore first-line selection, navigate resistance & translate mutational analysis into therapeutic decisions with coordinated team-based care. 🎯 Sharpen your CML strategy—register today! mdsc.pe/4zRXX6p #ASH26
210
🧪 Advancing care for systemic mastocytosis starts with the latest evidence happening at #ASH26!
Explore clinical trial findings, assess disease control, and enhance interprofessional treatment decisions.
🚀 Stay informed—join this educational activity! mdsc.pe/4yfvJ3h
210
Proud to sponsor Caregiver Central at @BloodCancerUtd New Jersey's Light The Night in Mercer County. 🏮 Better care starts when clinician education reflects patient and caregiver realities.
pmlive.com/pmhub/medscape_ed…
#LightTheNight #BloodCancerUnited
311
🧠 What does treatment success really look like in hemophilia? Move beyond bleeding rates, compare meaningful differences across therapies, and personalize care around the factors that matter to each patient. 🪄 Bring a fresh perspective to hemophilia care! mdsc.pe/4irU5mb
#ASH26
191
Advance your practice with new education on oral SERD eligibility in EBC. Gain expert insight into landmark trials, learn exactly who qualifies for novel therapies, and elevate the care you deliver and the outcomes you can achieve for the patients you treat every day.
.mdsc.pe/4z5AwF8
243
📌 #ASH26 is BACK! 🚀 Ready to bring bispecific antibodies into R/R MM care? Review key🔑 trial data, navigate barriers to implementation, and explore strategies to manage AEs while expanding access. 🧩 Build individualized care plans with confidence. Save your spot! mdsc.pe/3Sy3Apg
253
🔮 Is your patient’s SM truly under control? Dive into emerging evidence across the spectrum of systemic mastocytosis and 🧬 sharpen your ability to recognize when advanced treatment may be needed. 📣 Bring the latest evidence into practice! mdsc.pe/4yhO28u #ASH26
216
















